Accessibility Menu
Imagion Biosystems logo

Imagion Biosystems

(ASX) IBX

Current PriceA$0.02
Market CapA$7.85M
Since IPO (2017)-100%
5 Year-100%
1 Year+33%
1 Month+14%

Imagion Biosystems Financials at a Glance

Market Cap

A$7.85M

Revenue (TTM)

A$2.69M

Net Income (TTM)

-A$6.38M

EPS (TTM)

-A$0.02

P/E Ratio

-1.03

Dividend

A$0.00

Beta (Volatility)

-0.13 (Low)

Price

A$0.02

Volume

370,223

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.01 - A$0.06

Estimated Earnings Date

Feb 26, 2026

IBX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imagion Biosystems

Industry

Healthcare Equipment and Supplies

CEO

Isaac J. Bright, MD, MBA

Headquarters

San Diego, CA 92121, US

IBX Financials

Key Financial Metrics (TTM)

Gross Margin

-23%

Operating Margin

-162%

Net Income Margin

-167%

Return on Equity

0%

Return on Capital

2%

Return on Assets

-2%

Earnings Yield

-97.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$7.85M

Shares Outstanding

490.59M

Volume

370.22K

Avg. Volume

2.63M

Financials (TTM)

Gross Profit

-A$8.81K

Operating Income

-A$3.58M

EBITDA

-A$3.58M

Operating Cash Flow

-A$4.04M

Capital Expenditure

A$4.00

Free Cash Flow

-A$4.04M

Cash & ST Invst.

A$1.85M

Total Debt

A$2.56M

Imagion Biosystems Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$4.37K

+99.4%

Gross Margin

0.00%

N/A

Market Cap

A$7.85M

N/A

Market Cap/Employee

A$713.58K

N/A

Employees

11

N/A

Net Income

-A$2.65M

+44.7%

EBITDA

-A$2.40M

+65.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

A$1.85M

+713.6%

Total Debt

A$2.56M

-57.5%

Accounts Receivable

A$34.20K

-53.6%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

-100.0%

Short Term Debt

A$2.56M

-8.3%

Return on Assets

-2.11%

N/A

Return on Invested Capital

1.93%

N/A

Free Cash Flow

-A$2.27M

+8.0%

Operating Cash Flow

-A$2.27M

+1.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IRX.AXInhaleRx Limited
A$0.03+0.00%
ACR.AXAcrux Limited
A$0.02-5.56%
ZLD.AXZelira Therapeutics Limited
A$0.50+0.00%
HIQ.AXHITIQ Limited
A$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$160.95+0.19%
AALAmerican Airlines Group
$14.98+0.02%
NOKNokia
$14.80+0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.59+0.04%

Questions About IBX

What is the current price of Imagion Biosystems?

Imagion Biosystems is trading at A$0.02 per share.

What is the 52-week range for Imagion Biosystems?

Over the past 52 weeks, Imagion Biosystems has traded between A$0.01 and A$0.06.

How much debt does Imagion Biosystems have?

As of the most recent reporting period, Imagion Biosystems reported total debt of A$2.56M.

How much cash does Imagion Biosystems have on hand?

Imagion Biosystems reported A$1.85M in cash and cash equivalents in its most recent financial results.

What is Imagion Biosystems’s dividend yield?

Imagion Biosystems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.